 | Up a level |
Jump to: 2017
Number of items: 1.
2017
Burmester, Gerd R., McInnes, Iain B., Kremer, Joel, Miranda, Pedro, Korkosz, Mariusz, Vencovsky, Jiri 
ORCID: 0000-0002-0851-0713, Rubbert-Roth, Andrea, Mysler, Eduardo, Sleeman, Matthew A., Godwood, Alex, Sinibaldi, Dominic, Guo, Xiang, White, Wendy I., Wang, Bing, Wu, Chi-Yuan, Ryan, Patricia C., Close, David and Weinblatt, Michael E.
(2017).
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis.
Ann. Rheum. Dis., 76 (6).
S. 1020 - 1031.
LONDON:
BMJ PUBLISHING GROUP.
ISSN 1468-2060